Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 May 10;16(1):70.
doi: 10.1186/s12890-016-0238-9.

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities

Margarethe E Wacker  1 , Rudolf A Jörres  2 , Annika Karch  3 , Sarah Wilke  4 , Joachim Heinrich  5 , Stefan Karrasch  2   5   6 , Armin Koch  3 , Holger Schulz  5 , Henrik Watz  7 , Reiner Leidl  8   9 , Claus Vogelmeier  10 , Rolf Holle  8 ; COSYCONET-Consortium
Affiliations
Comparative Study

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities

Margarethe E Wacker et al. BMC Pulm Med. .

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) influences different aspects of patient's health-related quality of life (HRQL). While disease-specific HRQL instruments focus on symptoms and functional impairments, generic instruments cover a broader view on health. This study compares the generic EQ-5D-3 L and two disease-specific questionnaires (St.-George's Respiratory Questionnaire (SGRQ-C), COPD Assessment Test (CAT)) in a comprehensive spectrum of COPD disease grades with particular attention on comorbidities and assesses the discriminative abilities of these instruments.

Methods: Using data from the baseline visit of the German COPD cohort COSYCONET, mean HRQL scores in different COPD grades were compared by linear regression models adjusting for age, sex, education, smoking status, BMI, and low vs. high number of comorbidities or a list of several self-reported comorbid conditions. Discriminative abilities of HRQL instruments to differentiate between COPD grades were assessed by standardized mean differences.

Results: In 2,291 subjects in COPD GOLD grades 1-4 EQ-5D-3 L utility, EQ-5D VAS, SGRQ, and CAT were found able to discriminate between COPD grades, with some limitations for the EQ-5D utility in mild disease. Both generic and disease-specific HRQL instruments reflected the burden of comorbid conditions. The SGRQ showed the best discrimination between COPD grades and was less influenced by comorbidities, while EQ-5D utility put a higher weight on comorbid conditions. For all instruments, psychiatric disorders and peripheral artery disease showed the strongest negative associations with HRQL.

Conclusion: All HRQL instruments considered reflect considerable impairment of HRQL in COPD patients, worsening with increasing COPD grade and number of comorbidities. Findings may support clinical assessment, choice of HRQL instrument in future studies, and parameterization of decision-analytic models.

Keywords: Chronic obstructive pulmonary disease; Cohort study; Comorbidity; Health-related quality of life; Questionnaires; Utility.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Adjusted mean EQ-5D utilities, EQ-5D VAS, CAT score, SGRQ score by COPD grade 1-4 and comorbidity group
Fig. 2
Fig. 2
Standardized absolute mean differences between COPD grades
See this image and copyright information in PMC

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Update 2015). Available from: http://www.goldcopd.org/ Accessed 20 Jan 2016.
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Koskela J, Kilpelainen M, Kupiainen H, Mazur W, Sintonen H, Boezen M, Lindqvist A, Postma D, Laitinen T. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med. 2014;14:102. doi: 10.1186/1471-2466-14-102. - DOI - PMC - PubMed
    1. Srivastava K, Thakur D, Sharma S, Punekar YS. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. PharmacoEconomics. 2015;33(5):467–488. doi: 10.1007/s40273-015-0252-4. - DOI - PubMed
    1. Huber MB, Wacker ME, Vogelmeier CF, Leidl R. Comorbid Influences on generic health-related quality of life in COPD: a systematic review. PLoS One. 2015;10(7):e0132670. doi: 10.1371/journal.pone.0132670. - DOI - PMC - PubMed

Publication types